Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

206results about How to "Prolong life" patented technology

PROTACs compound for targeted degradation of PRMT5 and application of PROTACs compound

The invention discloses a PROTACs compound for targeted degradation of PRMT5 and application of the PROTACs compound. The PROTACs compound comprises a compound as shown in the following formula, and related analogues or pharmaceutically acceptable salts, metabolites or prodrugs of the compound: in the # imgabs0 # formula, X represents a ligand bound to PRMT5 protein, Z represents a ligand of E3 ubiquitin ligase, and Y represents a linking group for linking X and Z; according to the invention, CRBN is used as E3 ligase, and a series of PRMT5-targeted PROTAC degradation compounds are designed and synthesized. The compound can effectively induce PRMT5 degradation, significantly inhibit proliferation, growth, migration, infiltration, clone formation and metastasis of tumor cells, promote apoptosis of cancer cells, promote autophagy of the tumor cells, prevent or overcome drug resistance of BTK inhibitors and / or prolong the lifetime of tumor patients, and has wide application prospects.
Owner:KUNMING MEDICAL UNIVERSITY

A nano antibody against BCMA and its preparation method and application

The present invention discloses a nano antibody against BCMA and its preparation method and application, and relates to the field of biomedical technology. The present invention uses CRISPR / Cas9 technology to knock out B2M and TRAC genes in T cells to prepare universal CAR-T cells; the nano antibody targeting BCMA and the natural ligand SIRPα extracellular N-terminal V region of CD47, the transmembrane region of CD28, the intracellular signal region of 4-1BB and the intracellular signal region of CD3ζ are connected in series to form a dual-targeted chimeric antigen receptor for the treatment of multiple myeloma, so as to solve the high recurrence problem faced by CAR-T cell therapy in the treatment of multiple myeloma. The universal CAR-T cells prepared by the present invention have strong killing activity against multiple myeloma cells, effectively improve the treatment effect, and provide a key material for the subsequent development of adoptive immunotherapy with high efficiency and lasting anti-tumor activity.
Owner:SICHUAN UNIV

Breathing machine humidifying tank and breathing machine system

The utility model discloses a breathing machine humidifying tank and a breathing machine system, and relates to the field of medical instruments. The breathing machine humidifying tank comprises a tank body, a guide sleeve, a telescopic water bag and an operating rod. The tank main body is provided with a highest water line; the telescopic water bag is located in the tank body and horizontally arranged, the top of the telescopic water bag is higher than the highest water line, the telescopic water bag comprises a telescopic sleeve and a hard end plate, one end of the telescopic sleeve is connected with the tank body, the hard end plate is connected with the other end of the telescopic sleeve, and a water suction and drainage hole is formed in the hard end plate and lower than the highest water line. The guide sleeve and the telescopic water bag are arranged in the same direction, and the guide sleeve is connected with the tank body and corresponds to the telescopic water bag in position. And the operating rod penetrates through the guide sleeve, is matched with the guide sleeve and is sealed with the guide sleeve, and the operating rod is connected with the hard end plate. The breathing machine humidifying tank is installed on the breathing machine main machine, and a temperature and humidity sensor and a push-pull structure are arranged in a matched mode to obtain the breathing machine system. According to the utility model, the temperature and humidity of the humidified air at the patient end can be optimal.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Application of GABA (gamma-aminobutyric acid) driven by lactobacillus rhamnosus in treatment of cerebral malaria of mice

The invention belongs to the technical field of biomedicine, and particularly relates to application of GABA (gamma-aminobutyric acid) driven by lactobacillus rhamnosus to treatment of cerebral malaria of mice. According to the invention, the obviously enriched lactobacillus muricatum is found, and the lactobacillus muricatum is proved to be capable of generating GABA (gamma-aminobutyric acid). Afterwards, on the mouse cerebral malaria model, under the condition that the lactobacillus rhamnosus and the GABA are independently used or auxiliary dihydroartemisinin is used, the effect of the lactobacillus rhamnosus and the GABA on improving and treating the mouse cerebral malaria is evaluated. Results show that the strain and the metabolite GABA thereof can effectively improve behavioristics of mice and immune pathological injuries of all organs, reduce protozoemia and prolong the lifetime of the mice whether the strain is independently used or combined with dihydroartemisinin, and can effectively treat cerebral malaria of the mice compared with the strain which is independently used with drugs. The invention provides a brand-new solution for treating severe malaria, especially human brain malaria, caused by malignant malaria from the perspective that the probiotics drive metabolites of the probiotics to assist the anti-malarial drug in treating rat brain malaria.
Owner:HUBEI UNIV OF MEDICINE +1

Application of PABPC3 as marker for evaluating prognosis of metastatic ovarian cancer

The invention discloses application of PABPC3 as a marker for evaluating prognosis of metastatic ovarian cancer, and belongs to the technical field of biological diagnosis and medicine. Specifically, differential genes in an in-situ ovarian cancer and a metastatic ovarian cancer in a database are screened, and are combined with differential genes related to ovarian cancer prognosis in a pan-cancer database, so that a gene PABPC3 with remarkable differential expression is obtained. The influence of the gene PABPC3 on the activity, migration ability and the like of ovarian cancer cells is researched through cell experiments and in-vivo experiments, and the feasibility of the marker in evaluation of ovarian cancer prognosis is proved. Meanwhile, the invention also discovers that the expression of the knock-down gene PABPC3 can inhibit the metastasis of cancer cells. Therefore, the invention provides a novel strategy for detecting and treating ovarian cancer metastasis, which is expected to overcome the defects of the traditional detection and treatment mode, and provides a new choice for clinic.
Owner:SUZHOU UNIV

Wound-targeted intelligent nano-drug as well as preparation method and application thereof

The invention discloses a wound-targeted intelligent nano-drug as well as a preparation method and application thereof. The wound-targeted intelligent nano-drug comprises a platelet membrane and drug-loaded nano-particles, wherein the platelet membrane coats the drug-loaded nano-particles; the drug-loaded nanoparticles contain a tumor angiogenesis inhibitor; the surface of the platelet membrane is connected with an anti-PDL1 antibody. The wound-targeted intelligent nano-drug can significantly improve the curative effect of a tumor angiogenesis inhibitor (sorafenib) and anti-PDL1 combined use, improve the biological distribution of the drug, reduce the toxic and side effects caused by the combined use of the sorafenib and anti-PDL1, greatly reduce the postoperative recurrence rate of early liver cancer, has a strong postoperative recurrence inhibition capability, and has a good application prospect. The biological safety is relatively excellent.
Owner:THE GBA NAT INST FOR NANOTECHNOLOGY INNOVATION

Antigen peptide polymer vesicle tumor vaccine as well as preparation method and application thereof

The invention discloses an antigen peptide polymer vesicle tumor vaccine as well as a preparation method and application thereof. The antigen peptide polymer vesicle tumor vaccine is obtained by assembling and cross-linking a polymer pre-grafted with antigen peptide and a block polymer and loading an immunologic adjuvant through electrostatic interaction. The vesicle system disclosed by the invention has the advantages of small size, simplicity and controllability in preparation, excellent biocompatibility, high in-vivo circulation stability, targeting of main immune organs, intracellular delivery of antigen peptides and the like. The vesicle nano vaccine displaying the antigen peptide on the surface and encapsulating the immunologic adjuvant can promote dendritic cell maturation and antigen presentation, improve the specific response of mice to tumor-associated antigens, effectively inhibit tumor growth, remarkably prolong the lifetime of tumor-bearing mice and induce a strong immune protection effect, and is high in safety and easy to popularize. A multifunctional'ready-to-use 'nano vaccine concept is embodied, a flexible platform is provided, and different peptide antigens and / or adjuvants can be used for treating different cancers.
Owner:SUZHOU UNIV

Nanoparticles for generating CAR-T in vivo and application thereof

The invention provides nano-particles for generating CAR-T in vivo and application of the nano-particles, and belongs to the technical field of medical preparations. The nanoparticles are nanoparticles which are coupled with a CD7 antibody and entrapped with mRNA (messenger Ribonucleic Acid); the mRNA is obtained by transcription of a target gene; the target gene comprises a TROP2 single-chain antibody; the nucleotide sequence of the TROP2 single-chain antibody is as shown in SEQ ID NO: 1. The nucleotide sequence of the TROP2 single-chain antibody is optimized, the CAR containing the TROP2 single-chain antibody is constructed, then the CAR is transcribed to obtain mRNA, LNP entrapped with mRNA is prepared, then the CD7 antibody subjected to amino acid sequence optimization is adopted to be coupled with the LNP entrapped with mRNA, the transfection efficiency of the CD7 antibody in T cells is high, the CD7 antibody is injected into a mouse tumor model, and the lifetime of mice can be prolonged; t cells transfected by the T cell transfecting agent have high killing efficiency on HELA cells and LOVO cells.
Owner:SHANDONG RES INST OF ADULT CELL IND TECH CO LTD

Oncolytic virus VSV-aPDL1 / aCD137 expressing bispecific antibody as well as construction method and application of oncolytic virus VSV-aPDL1 / aCD137

The invention relates to an oncolytic virus VSV-aPDL1 / aCD137 for expressing a bispecific antibody as well as a construction method and application of the oncolytic virus VSV-aPDL1 / aCD137. The preparation method comprises the following steps: firstly designing aPDL1 / aCD137, then synthesizing an aPDL1 / aCD137 gene in vitro, amplifying the aPDL1 / aCD137 gene, connecting the aPDL1 / aCD137 gene to a pT7-VSV whole genome plasmid to obtain a virus whole genome plasmid pT7-VSV-aPDL1 / aCD137, and then co-transfecting the plasmid and a helper plasmid to a 293T cell to obtain the VSV-aPDL1 / aCD137 oncolytic virus. According to the present invention, the local anti-tumor immune response of the tumor is activated through the virus, the infiltration of the lymphocyte to the tumor tissue is recruited, the anti-PD-L1 / anti-CD137 bispecific antibody is expressed, the inhibition of the PD-1 / PD-L1 pathway on the T cell is blocked, and the inhibition signal of the PD-1 / PD-L1 pathway on the tumor cell surface is reversed into the CD137 signal of the activated T cell, such that the functional failure of the T cell caused by the PD-1 / PD-L1 pathway can be blocked, and the anti-tumor immune response of the tumor can be inhibited; the function and viability of T cells can be further improved, long-term immune surveillance on tumors is realized, and long-acting anti-tumor immune response is generated. Experiments show that the oncolytic virus can significantly prolong the lifetime of tumor-bearing mice, and a new strategy is provided for development of solid tumor drugs.
Owner:PEOPLES HOSPITAL OF HENAN PROV

Pharmaceutical composition for treating liver cancer

The invention relates to the technical field of biological medicines, and provides a pharmaceutical composition for treating liver cancer, which is prepared from the following raw material medicines in parts by weight: 3 to 8 parts of radix paeoniae rubra, 1 to 3 parts of fructus sophorae, 3 to 10 parts of rhizoma polygoni cuspidati, 3 to 20 parts of spica prunellae, 3 to 20 parts of herba hedyotidis diffusae, 3 to 10 parts of herba violae, 2 to 5 parts of turtle shell, 1 to 5 parts of radix angelicae sinensis, 1 to 3 parts of rhizoma curcumae, 1 to 3 parts of apios fortunei maxim and 3 to 5 parts of fructus polygoni orientalis. According to the technical scheme, the problems that in the prior art, after radiotherapy and chemotherapy are conducted on patients, obvious side effects can be generated, such as the symptoms of inappetence, nausea and vomiting, diarrhea, stomachache, dental ulcer and the like, and some patients have the symptoms of listlessness, weakness, shortness of breath, alopecia and the like are solved.
Owner:HANGZHOU ZHONGFUTANG TRADITIONAL CHINESE MEDICINE HOSPITAL CO LTD

Biomarker for predicting prognosis of intrahepatic cholangiocarcinoma patient, prediction model and application

The invention discloses a biomarker for predicting prognosis of an intrahepatic cholangiocarcinoma patient, a prediction model and application, and belongs to the field of biomedicine. According to the invention, single cell sequencing is carried out on matched intrahepatic cholangiocarcinoma and para-carcinoma tissues by using a BD Rhapsody platform, a tumor cell subset taking SPINK1 as a representative gene is screened out by using single cell sequencing data, and differential expression analysis is carried out on the subset and other epithelial cell subpopulations to obtain 249 differential genes. The differential genes are subjected to machine learning, a GBM model with the optimal prediction efficiency is selected, and a prediction model which contains 205 genes and is used for predicting the prognosis of the intrahepatic cholangiocarcinoma patient is established according to the GBM model. According to the prognosis prediction model, the prognosis prediction efficiency of the intrahepatic cholangiocarcinoma patient is improved, high-risk people can be more sensitively found, and key monitoring and more personalized treatment are carried out on the people, so that the death rate of the intrahepatic cholangiocarcinoma patient is reduced, and the lifetime of the patient is prolonged.
Owner:NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV

Recombinant oncolytic virus VSV-sPD1IL15RaIL15 as well as construction method and application thereof

PendingCN119101665Areverse failureLong-lasting anti-tumor immune responsePeptide/protein ingredientsMicroorganism based processesNatural Killer Cell Inhibitory ReceptorsCD8
The invention relates to a construction method and application of a recombinant oncolytic virus VSV-sPD1IL15RaIL15. The recombinant oncolytic virus VSV-sPD1IL15RaIL15 is constructed by using homologous recombination, and the recombinant oncolytic virus VSV-sPD1IL15RaIL15 can be used for preparing the recombinant oncolytic virus. The preparation method comprises the following steps: firstly designing sPD1 and IL15RaIL15, then fusing the sPD1 and the IL15RaIL15, synthesizing a sPD1IL15RaIL15 gene, amplifying the sPD1IL15RaIL15 gene, inserting the sPD1IL15RaIL15 gene into an ATU region of a VSV whole genome cDNA cloning plasmid pT7-VSV by using a homologous recombination method to obtain a virus whole genome plasmid pT7-VSV-sPD1IL15RaIL15, and co-transfecting the virus whole genome plasmid pT7-VSV-sPD1IL15RaIL15 and an auxiliary plasmid to a 293T cell to prepare the VSV-sPD1IL15RaIL15 oncolytic virus. According to the oncolytic virus, specific anti-tumor immunity is activated, and sPD1IL15RaIL15 is locally expressed in a tumor, so that a long-acting anti-tumor immune response is generated. When the oncolytic virus is used for treating solid tumors, the functions of tumor specific immune cells in a tumor microenvironment can be improved, infiltration of CD8 + T cells and NK cells can be promoted, and the lifetime of tumor-bearing mice can be remarkably prolonged.
Owner:张永辉

Prediction and evaluation method and system for lung cancer sample

The invention relates to the technical field of prediction and evaluation of lung cancer samples, and discloses a prediction and evaluation method of a lung cancer sample, which comprises the following steps: collecting clinical information of a lung cancer patient, acquiring biological data of the lung cancer sample, sorting medical image data, extracting key genes, proteins or pathway characteristics from the biological data, important features related to the lung cancer are screened by using a statistical method or a machine learning algorithm, a proper machine learning or deep learning model is selected according to data characteristics and a prediction target, and the interpretability, stability and calculation complexity of the model are considered. According to the method, tumors with high-risk characteristics, such as tumors with high invasiveness and high metastasis potential, can be found and intervened in time through prediction and evaluation of lung cancer samples, so that the disease progress is delayed, the treatment effect is improved, the treatment effect and disease change can be monitored through regular prediction and evaluation of the lung cancer samples in the treatment process, and the treatment effect is improved. The treatment scheme is adjusted in time, and the maximization of the treatment effect is ensured.
Owner:SHENZHEN YUCE BIOTECHNOLOGY CO LTD

Severed finger storing and transferring device

The severed finger storing and transferring device comprises a cup body and a cup cover, the outer wall of the cup body and the outer wall of the cup cover are both made of heat insulation materials, and the cup cover covers a cup opening of the cup body. A storage cavity filled with cold water is arranged in the cup body, an opening of the storage cavity faces upwards and is communicated with a cup opening, and severed fingers are placed in the storage cavity from the cup opening. A plug is arranged below the cup cover, and the plug is placed in the opening of the storage cavity after the cup cover is closed, so that the severed fingers are completely immersed in cold water in the storage cavity for refrigeration. A display screen is arranged on the cup cover, a sensor is arranged on the end face of the plug and electrically connected with the display screen, and the display screen displays the temperature value of the storage cavity. After the cup cover is closed, the severed finger is pushed by the chock plug to be completely immersed in cold water of the storage cavity for refrigeration; the temperature value of the storage cavity is displayed through the display screen on the cup cover, medical staff can monitor the refrigeration temperature of the severed finger in real time by checking the display screen, the refrigeration temperature is kept at about 4 DEG C, the life of the severed finger is prolonged, and the severed finger can be prevented from being frozen due to the too low refrigeration temperature.
Owner:SHANGHAI YIJA TRADING CO LTD

Application of deubiquitinating enzyme inhibitor and nucleic acid molecule in preparation of medicine for treating autoimmune disorder diseases

ActiveCN119097627Aprolong lifeInhibit interferon responseOrganic active ingredientsImmunological disordersDiseaseDeubiquitinating enzyme
The invention discloses application of a deubiquitinating enzyme inhibitor and a nucleic acid molecule in preparation of a medicine for treating autoimmune disorder diseases, and relates to the technical field of biological medicines. According to the medicine for treating the autoimmune disorder disease, the activity of ubiquitinase USP8 is inhibited through the deubiquitinase USP8 inhibitor, MDA5 is degraded, and therefore antiviral signal transduction and autoimmunity are inhibited. After the USP8 is inhibited by the small-molecule inhibitor, the lifetime of the mouse can be obviously prolonged; in PBMC cells of a patient with MDA5 positive dermatomyositis, the interferon reaction can be remarkably inhibited by inhibiting USP8 through a small-molecule inhibitor. Therefore, the deubiquitinating enzyme inhibitor, the nucleic acid molecule, the recombinant vector and the recombinant cell have good application prospects in treatment of autoimmune disorder diseases.
Owner:SICHUAN ACADEMY OF MEDICAL SCI SICHUAN PROVINCIAL PEOPLES HOSPITAL

Engineered immune cell for overexpressing integrin as well as preparation and application of engineered immune cell

The invention relates to an engineered immune cell for overexpressing integrin as well as preparation and application of the engineered immune cell. The engineered immune cell expresses integrin beta1 or integrin beta3. The expression of the integrin beta1 or the integrin beta3 can improve the in-vitro migration ability of the T cells, enhance the in-vitro tumor killing ability of the T cells, improve the in-vivo anti-tumor ability of the T cells and improve the infiltration proportion in T cell tumors. The T cell overexpressing the integrin beta1 or the integrin beta3 provided by the invention can enhance the infiltration capacity of the T cell and improve the effector function of the T cell so as to promote the anti-tumor capacity of the T cell, and is suitable for clinical treatment of any adoptive immunotherapy, including clinical treatment of tumors, infection and autoimmune diseases.
Owner:SUZHOU INST OF SYST MEDICINE

Gadolinium-based sulfonamide complex with radiotherapy sensitization effect as well as preparation and application thereof

The invention belongs to the technical field of biological medicines, and particularly relates to a gadolinium-based sulfonamide complex with a radiotherapy sensitization effect as well as preparation and application of the gadolinium-based sulfonamide complex. The preparation method comprises the following steps: dispersing sulfonamides and PVP in a mixed solution of ethanol and ethylene glycol, and stirring at room temperature to obtain a reaction solution A; dropwise adding Gd (NO3) 3.6 H2O into the reaction solution A, and continuously stirring to obtain a reaction solution B; and carrying out solvothermal reaction on the reaction solution B to obtain the gadolinium-based sulfonamide complex. The gadolinium-based sulfonamide complex prepared by the invention can increase the radiotherapy sensitivity by adjusting the tumor acidic microenvironment. Experiments prove that the gadolinium-based sulfonamide complex can effectively enhance the radiotherapy treatment effect, promote tumor cell apoptosis and slow down the tumor growth speed when being used in cooperation with radiotherapy.
Owner:金凤实验室

Nanometer material suitable for multi-mode diagnostic imaging and targeted photodynamic and photo-thermal cancer therapy as well as preparation and application of nanometer material

The invention provides a nano material suitable for multi-mode diagnostic imaging and targeted photodynamic (PDT) and photo-thermal (PTT) cancer therapy, and belongs to the field of nano biomedicine. According to the invention, an upconversion material (NaYF4: Yb / Er / Gd) and a photo-thermal material (Bi2Se3) are taken as a core, mesoporous silica is taken as a shell, and a photosensitizer (Ce6) and lipid / PEG and acidity-triggered membrane (ATRAM) peptide coated on the surface of the shell are loaded. The PDT and PTT synergistic anticancer effect achieved through near-infrared laser induction is achieved, magnetic resonance imaging, thermal imaging and fluorescence imaging of tumors can be achieved, and the requirement for diagnosis and treatment integration is met. In addition, the in-vivo lifetime of the nano-carrier is effectively prolonged through lipid / PEG, and aggregation and premature degradation of the nano-carrier are prevented; and the pH-mediated acidity-triggered membrane peptide is utilized to improve the uptake of cancer cells to the nano-carrier, so that the effect of the nano-carrier and the cancer cells is enhanced.
Owner:THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV

Organic el element material, organic el element, display device, and illumination device

Disclosed is an organic EL element material represented by the following general formula (1): wherein, in the general formula (1), any one of X1 to X3 is a nitrogen atom, and others are methine groups; L1 is a substituted or unsubstituted phenylene group, a substituted or unsubstituted naphthylene group, or substituted or unsubstituted anthrylene group; L2 is single bond, a substituted or unsubstituted phenylene group, a substituted or unsubstituted naphthylene group, or a substituted or unsubstituted anthrylene group, in which when these groups are substituted, the substituent is an alkyl group or an alkoxy group; A is a phenyl group or a pyridyl group; and n is 0 or 1. An organic EL element excellent in luminance efficiency and durability life is provided.
Owner:TORAY INDUSTRIES INC

Targeted inhibitor of Mmrn1, inhibition method and application

The invention relates to the field of biological medicine, in particular to an Mmrn1 targeted inhibitor, an inhibition method and application. According to the application disclosed by the invention, firstly, the relationship between the expression of the MMRN1 gene in the acute myelogenous leukemia (AML) and the regulation and control of a'siglecan-siglecc 'axis is creatively disclosed. Therefore, the invention firstly provides a small interfering RNA (Ribonucleic Acid) targeting the Mmrn1 in the leukemia stem cell, and an application of the small interfering RNA in preparation of a'sialic acid glycan-siglecc 'axis immune checkpoint inhibitor.
Owner:CHONGQING MEDICAL UNIVERSITY

A method for preparing cell-derived exosomes, products and uses thereof

ActiveCN121518393BSafe and controllable local immune activationOvercome security bottlenecksBacteriaPeptide/protein ingredientsLocal immunityTumor therapy
The application discloses a method for preparing cell-derived exosomes and products and applications thereof, and the method comprises the following steps: co-culturing immune-activated programmable cells with a stimulating agent with immune-activation effect, and collecting the cell-derived exosomes with immune activity by a natural secretion collection method or an artificial extrusion collection method. The application has safe and controllable local immune activation, and the immune activation strategy based on the exosomes fully overcomes the safety bottleneck of traditional live bacterial preparations in tumor treatment. By replacing live bacteria with engineered exosomes, not only potential risks such as systemic inflammatory response and infection are effectively avoided, but also the local controllability of immune stimulation signals is ensured, the precise activation and directional regulation of tumor region immune cells are realized, the tumor microenvironment is reshaped, the anti-tumor effect is strengthened, and the broad-spectrum cross-tumor potential is verified across models.
Owner:CHINA PHARM UNIV

Battery module and battery pack comprising same

The present disclosure relates to a battery module and a battery pack including same, and a battery module according to an embodiment of the present disclosure includes a battery cell stack formed by stacking a plurality of battery cells including a cooling surface and a wing folding surface; a module frame that houses the battery cell stack; an upper heat sink located in the upper part of the module frame; and a lower heat sink located in the lower part of the module frame, wherein the battery cell includes a first battery cell and a second battery cell, wherein the first battery cell is formed such that the cooling surface is located adjacent to the lower heat sink, and wherein the second battery cell is formed such that the cooling surface is located adjacent to the upper heat sink.
Owner:LG ENERGY SOLUTION LTD

Pharmaceutical composition for reversing pancreatic cancer gemcitabine resistance and application thereof

The invention discloses a pharmaceutical composition for reversing pancreatic cancer gemcitabine resistance. The pharmaceutical composition is prepared from active ingredients such as a radix sophorae flavescentis extract, a poria cocos extract, emodin, glucosamine, gambogic acid, tranilast and aspirin. The preparation method of the sophora flavescens extract and the poria cocos extract comprises the steps of raw material pretreatment, dynamic ultrasonic-microwave synergistic extraction, membrane separation and nanofiltration, high-efficiency countercurrent chromatography purification, vacuum low-temperature concentration, drying and the like. The pharmaceutical composition can be prepared into a plurality of pharmaceutical preparations such as tablets, capsules, granules, cream, injections and the like. The invention further provides a preparation method of the oral tablet for reversing pancreatic cancer gemcitabine drug resistance, and the pharmaceutical composition has a remarkable treatment effect on a drug resistance mechanism formed by up-regulating expression of SREBP1 by histone lactylation mediated PKM2 through an AKT / mTOR pathway. The pharmaceutical composition provided by the invention provides a new treatment choice for pancreatic cancer patients, and has an important clinical application value.
Owner:CHANGSHA FIRST HOSPITAL

Electrolytic capacitor

PendingEP4394832A4Reduce amountreduce the ESR of the electrolytic capacitorSolid electrolytic capacitorsLiquid electrolytic capacitors
An electrolytic capacitor 1 includes: a capacitor element 3 in which an anode foil 5 and a cathode foil 7 each having a dielectric oxide film face each other across a separator 6; a body case 2 that houses the capacitor element 3; and a sealing member 4 that seals the body case 2. An electrolyte and a hydrophilic compound are held between the anode foil 5 and the cathode foil 7. A sealing member deterioration preventing agent immiscible with the hydrophilic compound is arranged inside the body case 2.
Owner:SAN DENSHI INDS

STEEL FOR HIGH-PRESSURE HYDROGEN GAS ENVIRONMENTS, STRUCTURE OF STEEL FOR HIGH-PRESSURE HYDROGEN GAS ENVIRONMENTS, AND METHOD OF PRODUCING STEEL FOR HIGH-PRESSURE HYDROGEN GAS ENVIRONMENTS

ActiveIT202600027340T2Improve hydrogen embrittlement resistanceeasily and conveniently produced
Provided are a steel material and a method for producing the same. The steel material exhibits excellent hydrogen embrittlement resistance in a high-pressure hydrogen gas environment and is, therefore, suitable for use in hydrogen storage tanks, hydrogen line pipes, and the like. A steel material for a high-pressure hydrogen gas environment has a predetermined chemical composition. The steel material has a tensile strength of 560 MPa or higher, and a fracture toughness value KIH exhibited by the steel material in a high-pressure hydrogen gas atmosphere is 40 MPa ·m1 / 2 or higher.
Owner:JFE STEEL CORP

Method for culturing supernatant product in vitro through BCG (Bacillus calmette-guerin) and assisting in treating ovarian cancer

The invention relates to a method for in-vitro culture of BCG (Bacillus Calmette-Guerin) supernatant and adjuvant therapy of ovarian cancer, in particular to a method for preparing the in-vitro culture of BCG-Guerin supernatant and using the BCG-Guerin supernatant as an adjuvant therapy drug to be combined with a first-line platinum chemotherapeutic drug. The method comprises the following steps: firstly, culturing calmette-guerin bacteria in vitro, and collecting and purifying a culture supernatant product of the calmette-guerin bacteria to obtain the biological preparation with immunomodulatory activity. Then, according to the specific condition of the ovarian cancer patient, a personalized treatment scheme is formulated, the BCG in-vitro culture supernatant product is given to the patient in a proper mode, and meanwhile, the original platinum chemotherapy scheme is maintained. Clinical test results show that the method can significantly improve the curative effect of chemotherapy, reduce the side effect of chemotherapy, prolong the lifetime of a patient and improve the survival rate. The implementation of the invention provides a new and effective treatment means for ovarian cancer patients, and has wide clinical application prospects and profound social significance.
Owner:THE WEST CHINA SECOND UNIV HOSPITAL OF SICHUAN

Control method and system for electric power of steam turbine generator of nuclear power plant

A control method and system for an electric power of a steam turbine generator of a nuclear power plant, the method comprises: S10, collecting a real-time thermal power of a first loop in a nuclear power plant; S20, on the basis of a moving average method, calculating a real-time moving thermal power of the real-time thermal power within a first set time; S30, performing front-end heat generation amount calculation processing on the real-time moving thermal power and the real-time thermal power, so as to obtain front-end actual heat generation amount; S40, performing a heat generation amount prediction operation according to a preset target average thermal power, the real-time moving thermal power and the front-end actual heat generation amount, so as to obtain a predicted heat generation amount; and S50, performing a conversion and efficiency correction operation on the base of the predicted heat generation amount, so as to obtain a given electric power value which is used for controlling an electric power of a steam turbine generator, and returning to S10.
Owner:CHINA NUCLEAR POWER ENGINEERING COMPANY LTD +3

Traditional Chinese medicine composition for treating esophageal cancer as well as preparation method and application of traditional Chinese medicine composition

The invention provides a traditional Chinese medicine composition for treating esophageal cancer, the traditional Chinese medicine composition is prepared from the following medicines in parts by weight: 10-20 parts of codonopsis pilosula, 10-20 parts of garden balsam seed, 6-10 parts of gecko, 20-40 parts of salvia chinensis, 10-20 parts of prepared arisaema consanguineum schott, 10-20 parts of roasted fructus chebulae and 10-20 parts of trifoliate orange, the invention discloses a preparation method of the traditional Chinese medicine composition, and also discloses application of the traditional Chinese medicine composition and an anti-tumor medicine in preparation of a medicine for treating esophageal cancer. The traditional Chinese medicine composition is reasonable in formula principle and remarkable in effect, and has good clinical application value and social significance.
Owner:SHANGHAI CHEST HOSPITAL

Micro-inverter and grid-tied output control method and device therefor

A micro-inverter and a grid-tied output control method and device therefor. The micro-inverter comprises an inverter full-bridge circuit and an LC filter circuit. The LC filter circuit is grid-tied to a power grid by means of an output switch. The method comprises: acquiring a voltage amplitude, a frequency, and a phase of a power grid voltage by using phase locking; adjusting a power switching transistor driving an inverter full-bridge circuit to cause an output voltage of a micro-inverter to track the power grid voltage; and controlling the output switch to be turned off so that the micro-inverter works normally. According to the present application, before the output switch is turned off to grid-tie the micro-inverter, the power grid voltage is phase-locked and the output voltage of the micro-inverter is controlled to track the power grid voltage, so that damage to a power switching transistor caused by a current at the moment when the output switch is turned off can be effectively avoided, thereby effectively improving the reliability and the service life of the micro-inverter.
Owner:ALTENERGY POWER SYST

Colored-layer-forming composition, optical film, and display device

PendingEP4390474A4good color correction functionincrease heatAntifouling/underwater paintsElectrical apparatus
A composition for forming a colored layer includes a dye (A), an ionizing radiation-curable resin (B), a photoinitiator (C), and a solvent (D). The dye (A) contains a first colorant and a second colorant, the first colorant has a wavelength of maximum absorption in a range of 470 nm to 530 nm, and an absorption spectrum with a full width at half maximum of 15 nm to 45 nm, the second colorant has a wavelength of maximum absorption in a range of 560 nm to 620 nm, and an absorption spectrum with a full width at half maximum of 15 nm to 55 nm, and the ionizing radiation-curable resin (B) contains a resin having an amine structure.
Owner:TOPPAN INC